Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:43 AM
Ignite Modification Date:
2025-12-25 @ 1:43 AM
NCT ID:
NCT00771394
Eligibility Criteria:
Inclusion Criteria:
* Patients with benign prostatic hypertrophy who have been treated with tamsulosin for at least 6 weeks
* Patients with urgency episodes and frequent micturitions
* Written informed consent has been obtained
* Uroflowmetry-Q max ≥ 5 mL/sec, and Post Void Residual Volume \< 50 mL
Exclusion Criteria:
* Patients with suspected symptoms of OAB whose onset is only transient (drug-induced, psychogenic, etc.)
* Patients with obvious stress urinary incontinence
* Patients with complications or who have a past history of a bladder tumor
* Patients with urethral stricture or bladder neck stenosis
* Patients with a history of surgery causing damage to the pelvic plexus
* Patients with history of hypersensitivity to α receptor blockers, a/b receptor blockers, or anticholinergic drugs
* Patients with orthostatic hypotension, ulcerative colitis, hyperthyroidism, dementia or cognitive dysfunction, Parkinson's disease, or cerebrovascular disorder
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
50 Years
Study:
NCT00771394
Study Brief:
Protocol Section:
NCT00771394